These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 367656)

  • 1. Autoimmunological aspects of thromboangiitis obliterans (Buerger's disease).
    Smolen JS; Youngchaiyud U; Weidinger P; Kojer M; Endler AT; Mayr WR; Menzel EJ
    Clin Immunol Immunopathol; 1978 Oct; 11(2):168-77. PubMed ID: 367656
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for an HLA-linked resistance gene in Buerger's disease.
    de Moerloose P; Jeannet M; Mirimanoff P; Bouvier CA
    Tissue Antigens; 1979 Aug; 14(2):169-73. PubMed ID: 91227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA-A9 and HLA-B5 with Buerger's disease.
    McLoughlin GA; Helsby CR; Evans CC; Chapman DM
    Br Med J; 1976 Nov; 2(6045):1165-6. PubMed ID: 990826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA in Buerger's disease.
    Numano F; Sasazuki T; Koyama T; Shimokado K; Takeda Y; Nishimura Y; Mutoh M
    Exp Clin Immunogenet; 1986; 3(4):195-200. PubMed ID: 3274054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in thromboangiitis obliterans (Buerger's disease).
    Gulati SM; Madhra K; Thusoo TK; Nair SK; Saha K
    Angiology; 1982 Oct; 33(10):642-51. PubMed ID: 6751163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
    Papa M; Bass A; Adar R; Halperin Z; Schneiderman J; Becker CG; Brautbar H; Mozes E
    Surgery; 1992 May; 111(5):527-31. PubMed ID: 1598672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects of thromboangiitis obliterans (von Winiwarter-Buerger's disease).
    Berlit P; Kessler C; Reuther R; Krause KH
    Eur Neurol; 1984; 23(6):394-9. PubMed ID: 6391927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Population genetics, immunologic evaluation and Buerger's disease. Projection through a personal study comprising 127 cases of juvenile arteriopathy].
    Schmitt J; Schmidt C; Alan C; Haller C; Perrier P
    Bull Acad Natl Med; 1993 Oct; 177(7):1153-62; discussion 1162-4. PubMed ID: 8149255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of thromboangiitis obliterans: Gene polymorphism and immunoregulation of human vascular endothelial cells.
    Sun XL; Law BY; de Seabra Rodrigues Dias IR; Mok SWF; He YZ; Wong VK
    Atherosclerosis; 2017 Oct; 265():258-265. PubMed ID: 28864202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Buerger's disease, aortitis syndrome and HL-A].
    Yasuda K; Yokota A; Tanabe T
    Nihon Rinsho; 1978 Sep; 36(9):3171-5. PubMed ID: 722915
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenetics of peripheral arteriopathies.
    Mehra NK; Jaini R
    Clin Hemorheol Microcirc; 2000; 23(2-4):225-32. PubMed ID: 11321444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular sensitivity to collagen in thromboangiitis obliterans.
    Adar R; Papa MZ; Halpern Z; Mozes M; Shoshan S; Sofer B; Zinger H; Dayan M; Mozes E
    N Engl J Med; 1983 May; 308(19):1113-6. PubMed ID: 6835334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology and pathogenesis of Buerger's disease.
    Tanaka K
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S237-42. PubMed ID: 9951825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological studies in thromboangitis obliterans (Buerger's disease).
    Gulati SM; Singh KS; Thusoo TK; Saha K
    J Surg Res; 1979 Nov; 27(5):287-93. PubMed ID: 390247
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease).
    Halacheva KS; Manolova IM; Petkov DP; Andreev AP
    Scand J Immunol; 1998 Nov; 48(5):544-50. PubMed ID: 9822265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticardiolipin antibodies in patients with Buerger's disease].
    Cnotliwy M; Gutowski P; Szumiłowicz H; Kucharska E; Jastrzebska M; Ostanek L
    Wiad Lek; 1999; 52(7-8):332-6. PubMed ID: 10540577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two female nonsmoker Buerger's disease cases with anticardiolipin autoantibodies and a poor prognosis.
    Heper G; Kose S; Akkoc O; Amasyali B; Kilic A
    Int Heart J; 2005 May; 46(3):563-9. PubMed ID: 16043952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes in Buerger's disease. Endarteritis obliterans in young men.
    Roncon de Albuquerque R; Delgado L; Correia P; Torrinha JF; Serrão D; Braga A
    J Cardiovasc Surg (Torino); 1989; 30(5):821-5. PubMed ID: 2808505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboangiitis obliterans (Buerger's disease).
    Mishima Y
    Int J Cardiol; 1996 Aug; 54 Suppl():S185-7. PubMed ID: 9119522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.